Skip to main content

1-20 of 198 results for subject:Software

Subject X
Clinical trials

Type

House

Session

Year

Department

Member

More

Primary member

Answering member

Legislative stage

Legislation

Subject

More
Clinical trials (198)

Publisher


Show detailed: On Off
Results: 10 20 50 100
Sort by: Newest first Oldest first

Lords statement on the Government's national cancer plan for England.

Lead member
Baroness Merron
Department
Department of Health and Social Care
Type
Ministerial statements
Date
9 February 2026
Reference
853 cc80-92
House
House of Lords

My Lords, I begin by welcoming the publication of the national cancer plan and make it clear we fully share the Government’s desire to tackle cancer and to succeed in the fight against a condition that has affected almost every family in the country in one way or another. The...

Member
Earl Howe (Conservative)
Type
Proceeding contributions
Date
9 February 2026
Reference
853 cc83-4
House
House of Lords

My Lords, from these Benches, we very much welcome the national cancer plan and support its ambitions—and it is very ambitious. Many organisations and committees have called for an

integrated, long-term plan, so it is very good that the Government have listened and, in particular, have taken note of the...

Member
Baroness Walmsley (Liberal Democrat)
Type
Proceeding contributions
Date
9 February 2026
Reference
853 cc84-6
House
House of Lords

My Lords, I am grateful for the warm welcome from both Front Benches for the national cancer plan. This is a moment when we transform our cancer care and we make it personalised—we wrap it around the person instead of expecting it to be the other way around. The 62-day...

Member
Baroness Merron (Labour)
Type
Proceeding contributions
Date
9 February 2026
Reference
853 cc86-7
House
House of Lords

My Lords, I must declare my interests in palliative care over the years. I will not list them all now, but I had the pleasure of working on the palliative care commission under the chairmanship of Sir Mike Richards. From speaking to him, I am glad to learn that he...

Member
Baroness Finlay of Llandaff (Crossbench)
Type
Proceeding contributions
Date
9 February 2026
Reference
853 cc87-8
House
House of Lords

I am sorry to hear about the member of the noble Baroness’s family.

To the point about treatment, by 2028, every cancer patient will have access to a personal cancer care plan via the NHS app. Tailoring treatment and support through the whole care journey is important, including before the care...

Member
Baroness Merron (Labour)
Type
Proceeding contributions
Date
9 February 2026
Reference
853 c88
House
House of Lords

My Lords, I echo the praise of other noble Lords for the report. Professor Peter Johnson has done an enormously worthwhile job, and there is so much richness and so many good things in the report.

I will put a spotlight on the unfortunate framing that catching cancer is, largely speaking...

Member
Lord Bethell (Conservative; Conservative)
Type
Proceeding contributions
Date
9 February 2026
Reference
853 cc88-9
House
House of Lords

I am grateful for the noble Lord’s support for the cancer plan. I should have mentioned this. I will be honest: even as a Minister, I do not always pay full attention to the foreword, and I am sure that other former Ministers might share that, within a plan, but...

Member
Baroness Merron (Labour)
Type
Proceeding contributions
Date
9 February 2026
Reference
853 cc89-90
House
House of Lords

My Lords, I too support the national cancer plan, but I am not here to blow the Government’s trumpet. I will pick up on some of the points.

This is an ambitious plan, and that is good, because it might act as a catalyst for some progress. However, if that progress...

Member
Lord Patel (Crossbench)
Type
Proceeding contributions
Date
9 February 2026
Reference
853 c90
House
House of Lords

That last point will, of course, be drawn to the attention of the usual channels. I too would welcome a debate on this. Noble Lords might wish to note that when they have an opportunity to suggest or apply for debates.

The noble Lord’s last point was about elimination of cancer....

Member
Baroness Merron (Labour)
Type
Proceeding contributions
Date
9 February 2026
Reference
853 cc90-1
House
House of Lords

My Lords, I too recognise that this plan is a really good step forward in terms of the long-term plan for cancer sufferers. Many of our families have been touched by this awful disease, which is many and varied. However, I would like to focus on the innovation and research...

Member
Baroness Swinburne (Conservative)
Type
Proceeding contributions
Date
9 February 2026
Reference
853 cc91-2
House
House of Lords

The noble Baroness makes a very good point, particularly as we are in what I regard as a whole new area of scientific and technological advancement, and we have the chance to harness it.

In general terms, I can say to the noble Baroness that where, for example, there are regulatory...

Member
Baroness Merron (Labour)
Type
Proceeding contributions
Date
9 February 2026
Reference
853 c92
House
House of Lords

Statement on the Government's national cancer plan for England.

Lead member
Ashley Dalton
Department
Department of Health and Social Care
Type
Ministerial statements
Date
5 February 2026
Reference
780 cc452-460
House
House of Commons

With permission, I will make a statement on the Government’s national cancer plan for England.

A cancer diagnosis changes you forever. When I was diagnosed with metastatic breast cancer 18 months ago, I did not know whether I would be alive today, never mind standing at this Dispatch Box announcing a...

Member
Ashley Dalton (Labour)
Type
Proceeding contributions
Date
5 February 2026
Reference
780 cc452-4
House
House of Commons

I thank the Minister for advance sight of her statement. May I say right at the outset that we share the ambition to improve cancer survival and outcomes? Almost every family in Britain has been touched by cancer, and patients deserve timely diagnosis, treatment and proper support. I also recognise...

Member
Stuart Andrew (Conservative)
Type
Proceeding contributions
Date
5 February 2026
Reference
780 cc454-6
House
House of Commons

I thank the right hon. Member for his statement and questions, and particularly for his personal wishes.

Overseeing delivery is absolutely crucial. It is great that we have written a plan, but what matters is delivering it. We started delivery even before we had finished writing this plan; we are not...

Member
Ashley Dalton (Labour)
Type
Proceeding contributions
Date
5 February 2026
Reference
780 c456
House
House of Commons

I really welcome this plan, and the efforts of my hon. Friend the Minister and right hon. Friend the Secretary of State in putting it together. I will just raise one credit and one request to go a bit further.

First, when I had my cancer treatment eight years ago, I...

Member
Clive Betts (Labour)
Type
Proceeding contributions
Date
5 February 2026
Reference
780 cc457-431
House
House of Commons

I thank my hon. Friend for his question, for his expertise and for all that he has shared from his experience to help us develop this plan. I note how important specialist nurses are, but we are also doing more to help people navigate the NHS. I know exactly what...

Member
Ashley Dalton (Labour)
Type
Proceeding contributions
Date
5 February 2026
Reference
780 c431
House
House of Commons

I thank the Minister for advance sight of the statement and for her personal experience that has gone into this plan. After the Conservatives failed to invest in our NHS, it is no surprise that cancer survival in the UK is still around 10 to 15 years behind leading countries,...

Member
Helen Maguire (Liberal Democrat)
Type
Proceeding contributions
Date
5 February 2026
Reference
780 cc431-458
House
House of Commons

We listen to a lot of people on the need for a cancer plan. I want to take this opportunity to say that our friend Nathaniel Dye, who sadly died last week from stage 4 bowel cancer, challenged my right hon. Friend the Secretary of State to bring forward a...

Member
Ashley Dalton (Labour)
Type
Proceeding contributions
Date
5 February 2026
Reference
780 c458
House
House of Commons